Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance NASDAQ:EVOK opened at $0.55 on Wednesday. The company has a market cap of $4.69 million, a […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on LiqTech International (NASDAQ:LIQT)
Next post HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)